Halper Sadeh Investigates Repare, Axalta, and Blue Foundry Bancorp Mergers
ByAinvest
Tuesday, Dec 2, 2025 9:21 am ET1min read
AXTA--
FULT--
RPTX--
Halper Sadeh LLC is investigating Repare Therapeutics Inc.'s sale to XenoTherapeutics for potential violations of federal securities laws and breaches of fiduciary duties. Repare shareholders may be eligible for a cash payment of $1.82 per share plus a contingent value right. Additionally, the firm is investigating Axalta Coating Systems Ltd.'s sale to Akzo Nobel N.V. and Blue Foundry Bancorp's sale to Fulton Financial Corporation. Shareholders can click on the corresponding links to learn more about their rights and options.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet